We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
Cap. Flow
-$2.07B
Cap. Flow %
-17.42%
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$107M
2
GSK icon
GSK
GSK
+$58.9M
3
AVGO icon
Broadcom
AVGO
+$54M
4
UL icon
Unilever
UL
+$54M
5
MRVL icon
Marvell Technology
MRVL
+$48.3M

Sector Composition

Rank Sector Weight
1 Technology 11.5%
2 Communication Services 3.61%
3 Financials 3.6%
4 Healthcare 3.01%
5 Consumer Discretionary 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNT icon
801
RadNet
RDNT
$4.84B
$480K ﹤0.01%
6,873
-18,203
-73% -$1.34M
SNAP icon
802
CALL
Snap
SNAP
$7.6B
$474K ﹤0.01%
+44,000
New +$496K
WELL icon
803
Welltower
WELL
$175B
$468K ﹤0.01%
+3,712
New +$487K
RVMDW icon
804
Revolution Medicines Inc Warrant
RVMDW
$105M
$467K ﹤0.01%
+2,595,245
New +$767K
SATLW icon
805
Satellogic Inc Warrant
SATLW
$34.1M
$463K ﹤0.01%
+1,260,914
New +$299K
RUN icon
806
Sunrun
RUN
$2.38B
$463K ﹤0.01%
50,000
+30,148
+152% +$374K
PCVX icon
807
Vaxcyte
PCVX
$8.01B
$458K ﹤0.01%
+5,600
New +$556K
MNST icon
808
Monster Beverage
MNST
$93.2B
$456K ﹤0.01%
8,675
+3,857
+80% +$204K
SRPT icon
809
Sarepta Therapeutics
SRPT
$1.68B
$453K ﹤0.01%
3,724
-41,903
-92% -$5.14M
AMPS
810
DELISTED
Altus Power
AMPS
$445K ﹤0.01%
+109,220
New +$400K
BZFDW icon
811
BuzzFeed Inc Warrant
BZFDW
$763K
$440K ﹤0.01%
+2,444,027
New +$383K
BE icon
812
CALL
Bloom Energy
BE
$53.5B
$438K ﹤0.01%
+19,700
New +$345K
ASND icon
813
Ascendis Pharma A/S
ASND
$16.6B
$427K ﹤0.01%
3,100
ONC
814
BeOne Medicines Ltd
ONC
$33.8B
$422K ﹤0.01%
2,285
-4,553
-67% -$930K
AMPX.WS icon
815
Amprius Technologies Warrants
AMPX.WS
$383M
$417K ﹤0.01%
+1,173,680
New +$242K
STVN icon
816
Stevanato
STVN
$5.41B
$413K ﹤0.01%
+18,956
New +$380K
NOC icon
817
Northrop Grumman
NOC
$77.8B
$411K ﹤0.01%
+875
New +$440K
RIOT icon
818
Riot Platforms
RIOT
$8.31B
$408K ﹤0.01%
+40,000
New +$436K
BFLY.WS
819
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$405K ﹤0.01%
+3,188,004
New +$385K
IAS
820
DELISTED
Integral Ad Science
IAS
$398K ﹤0.01%
+38,079
New +$418K
CLF icon
821
CALL
Cleveland-Cliffs
CLF
$6.99B
$396K ﹤0.01%
42,100
-900
-2% -$10.8K
KRYS icon
822
PUT
Krystal Biotech
KRYS
$10.4B
$392K ﹤0.01%
2,500
-2,500
-50% -$443K
PI icon
823
Impinj
PI
$3.97B
$390K ﹤0.01%
+2,686
New +$509K
AG icon
824
First Majestic Silver
AG
$8.01B
$389K ﹤0.01%
+70,918
New +$458K
PM icon
825
PUT
Philip Morris
PM
$305B
$385K ﹤0.01%
3,200
-9,600
-75% -$1.21M

Similar funds

LMR Partners's Q4 2024 Portfolio in Review

As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.

Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.

  • LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
  • LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
  • LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
  • LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
  • LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
  • LMR Partners opened 534 new positions and closed 613 in Q4 2024.
  • LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.